Browsing by Author "Nanyonga, Stella Maris"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study(BMJ Open, 2022) Kiguba, Ronald; Byomire, Helen; Byomire Ndagije, Helen; Nambasa, Victoria; Katureebe, Cordelia; Zakumumpa, Henry; Nanyonga, Stella Maris; Nambi Ssanyu, Jacquellyn; Tregunno, Phil; Harrison, Kendal; Merle, Corinne S.; Raguenaud, Marie-Eve; Kitutu, Freddy EricPatients have contributed <1% of spontaneous adverse drug reaction (ADR) reports in Uganda’s pharmacovigilance database. Peer support combined with mobile technologies could empower people living with HIV (PLHIV) to report ADRs and improve ADR management through linkage to care. We seek to test the feasibility and effect of a peer support intervention on ADR reporting by PLHIV receiving combination antiretroviral therapy (cART) in Uganda; identify barriers and facilitators to the intervention; and characterise ADR reporting andItem National Antimicrobial Consumption: Analysis of Central Warehouses Supplies to In-Patient Care Health Facilities from 2017 to 2019 in Uganda(Tropical Medicine & Infection Disease, 2021) Sanyu Namugambe, Juliet; Delamou, Alexandre; Moses, Francis; Ali, Engy; Hermans, Veerle; Takarinda, Kudakwashe; Thekkur, Pruthu; Nanyonga, Stella Maris; Koroma, Zikan; Ngobi Mwoga, Joseph; Akello, Harriet; Imi, Monica; Kitutu, Freddy EricAntimicrobial consumption (AMC) surveillance at global and national levels is necessary to inform relevant interventions and policies. This study analyzed central warehouse antimicrobial supplies to health facilities providing inpatient care in Uganda. We collected data on antimicrobials supplied by National Medical Stores (NMS) and Joint Medical Stores (JMS) to 442 health facilities from 2017 to 2019. Data were analyzed using the World Health Organization methodology for AMC surveillance. Total quantity of antimicrobials in defined daily dose (DDD) were determined, classified into Access, Watch, Reserve (AWaRe) and AMC density was calculated. There was an increase in total DDDs distributed by NMS in 2019 by 4,166,572 DDD. In 2019, Amoxicillin (27%), Cotrimoxazole (20%), and Metronidazole (12%) were the most supplied antimicrobials by NMS while Doxycycline (10%), Amoxicillin (19%), and Metronidazole (10%) were the most supplied by JMS. The majority of antimicrobials supplied by NMS (81%) and JMS (66%) were from the Access category. Increasing antimicrobial consumption density (DDD per 100 patient days) was observed from national referral to lower-level health facilities. Except for NMS in 2019, total antimicrobials supplied by NMS and JMS remained the same from 2017 to 2019. This serves as a baseline for future assessments and monitoring of stewardship interventions.